← Back to Patent Explorer
US5510356A Expired / Lapsed US ⏱️ 0.0 years remaining

Bisquinolines and processes for their production and use to treat malaria

Assignee: BOARD OF REGENTS OF UNIVERSITY OF NEBRASKA ("BOARD")
•
Filing: 1991-10-03
•
Granted: 1996-04-23
•
Expires: 2011-10-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention relates to new bisquinolines useful in the treatment of malaria and to processes for the production thereof. The invention also relates to methods for the treatment of malaria and, in particular, to the treatment of chloroquine-resistant strains of malaria. The compounds of the invention have the following formula: <IMAGE> FORMULA I wherein R is a bivalent radical derived from an acyclic or cyclic hydrocarbon by removal of one hydrogen atom from each of two different carbon atoms. R' is hydrogen or lower alkyl (generally containing between about 1 and about 4 carbon atoms). X is hydrogen (-H), fluoro (-F), chloro (-Cl), bromo (-Br), trifluoromethyl (-CF3), cyano (-CN), or methylsulfoxide (-SOCH3). In its acyclic form, R generally contains at least two, and no more than about 12, carbon atoms and, preferably, is an unsubstituted straight or branched alkane. In its cyclic form, R contains at least three and, generally, no more than about eight carbon atoms and, preferably, is an unsubstituted cycloalkane. In a preferred embodiment, this invention relates to N,N-bis(7-chloroquinolin-4-yl)alkane diamines which are active against chloroquine-resistant malaria. The bisquinolines of this invention are useful agents against chloroquine-resistant malaria. +/--Trans-N1,N2-Bis(7-chloro-quinolin-4-yl)cyclohexane-1,2-diamine is highly preferred for treatment of chloroquine-resistant malaria. This compound is one of the most potent antimalarials discovered to date and is clearly unique in its in vivo activity -80% and 100% cure rates being achieved at doses of 160 and 320 mg/kg, respectively.

Inventors

  • 👤 Jonathan L. Vennerstrom

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 21:36
CPC Classifications
C; C07; C07D; C07D215/00; C07D215/02; C07D215/16; C07D215/38; C07D215/42; C07D215/46; Y; Y02; Y02A; Y02A50/00; Y02A50/30

Claims Analysis

Total Claims: 24
Claim 1
Independent Claim 92 words
A compound having the following formula: ##STR7## wherein R is a bivalent radical derived from an acyclic or cyclic hydrocarbon by removal of one hydrogen atom from each of two different carbon atoms; R' is hydrogen or lower alkyl, and wherein X is hydrogen (--H), halo, trifluoromethyl (--CF 3 ), cyano (--CN), or methylsulfoxide (--SOCH 3 ); and wherein, in its acyclic form, R contains at least three and no more than 12 carbon atoms, and in its cyclic form, R contains at least three and no more than eight carbon atoms.
Claim 2
Dependent Claim 92 words
A compound having the following formula: ##STR7## wherein R is a bivalent radical derived from an acyclic or cyclic hydrocarbon by removal of one hydrogen atom from each of two different carbon atoms; R' is hydrogen or lower alkyl, and wherein X is hydrogen (--H), halo, trifluoromethyl (--CF 3 ), cyano (--CN), or methylsulfoxide (--SOCH 3 ); and wherein, in its acyclic form, R contains at least three and no more than 12 carbon atoms, and in its cyclic form, R contains at least three and no more than eight carbon atoms.
Claim 3
Dependent Claim 91 words
A compound of the following formula: ##STR8## wherein R is selected from the group consisting of CH 2 CH(CH 3 ), (CH 2 ) 3 , (CH 2 ) 4 , (CH 2 ) 5 , (CH 2 ) 3 CH(CH 3 )CH 2 , (CH 2 ) 6 , (CH 2 ) 7 , (CH 2 ) 8 , (CH 2 ) 9 , CH 2 ) 10 , (CH 2 ) 11 , and (CH 2 ) 12 , and between C1 and C4 lower alkyl substituted derivatives thereof.
Claim 4
Dependent Claim 91 words
A compound of the following formula: ##STR8## wherein R is selected from the group consisting of CH 2 CH(CH 3 ), (CH 2 ) 3 , (CH 2 ) 4 , (CH 2 ) 5 , (CH 2 ) 3 CH(CH 3 )CH 2 , (CH 2 ) 6 , (CH 2 ) 7 , (CH 2 ) 8 , (CH 2 ) 9 , CH 2 ) 10 , (CH 2 ) 11 , and (CH 2 ) 12 , and between C1 and C4 lower alkyl substituted derivatives thereof.
Claim 5
Dependent Claim 39 words
A compound of the following formula: ##STR9## wherein X is hydrogen (--H), fluoro (--F), chloro (--Cl), bromo (--Br), trifluoromethyl (--CF 3 ), cyano (--CN), or methylsulfoxide (--SOCH 3 ) and n is a whole integer from 1 through 6.
Claim 6
Dependent Claim 39 words
A compound of the following formula: ##STR9## wherein X is hydrogen (--H), fluoro (--F), chloro (--Cl), bromo (--Br), trifluoromethyl (--CF 3 ), cyano (--CN), or methylsulfoxide (--SOCH 3 ) and n is a whole integer from 1 through 6.
Claim 7
Dependent Claim 13 words
The compound of claim 3 wherein n is 4 and X is chloro.
Claim 8
Dependent Claim 13 words
The compound of claim 2 wherein R is CH 2 CH(CH 3 ).
Claim 9
Dependent Claim 13 words
The compound of claim 2 wherein R is (CH 2 ) 3 .
Claim 10
Dependent Claim 13 words
The compound of claim 2 wherein R is (CH 2 ) 4 .
Claim 11
Dependent Claim 13 words
The compound of claim 2 wherein R is (CH 2 ) 5 .
Claim 12
Dependent Claim 17 words
The compound of claim 2 wherein R is (CH 2 ) 3 CH(CH 3 )CH 2 .
Claim 13
Dependent Claim 13 words
The compound of claim 2 wherein R is (CH 2 ) 6 .
Claim 14
Dependent Claim 13 words
The compound of claim 2 wherein R is (CH 2 ) 7 .
Claim 15
Dependent Claim 13 words
The compound of claim 2 wherein R is (CH 2 ) 8 .
Claim 16
Dependent Claim 13 words
The compound of claim 2 wherein R is (CH 2 ) 9 .
Claim 17
Dependent Claim 13 words
The compound of claim 2 wherein R is (CH 2 ) 10 .
Claim 18
Dependent Claim 13 words
The compound of claim 2 wherein R is (CH 2 ) 11 .
Claim 19
Dependent Claim 13 words
The compound of claim 2 wherein R is (CH 2 ) 12 .
Claim 20
Dependent Claim 19 words
An anti-malaria composition containing an effective amount of ±-Trans-N 1 , N 2 -Bis(7-chloroquinolin-4-yl)-cyclohexane-1,2-diamine in a pharmaceutically acceptable carrier.
Claim 21
Dependent Claim 19 words
An anti-malaria composition containing an effective amount of ±-Trans-N 1 , N 2 -Bis(7-chloroquinolin-4-yl)-cyclohexane-1,2-diamine in a pharmaceutically acceptable carrier.
Claim 22
Independent Claim 35 words
A method for the treatment of malaria comprising administering to a host an N,N-bis(7-substituted-quinolin-4-yl)alkane diamine of claims 1-17 in a pharmaceutically acceptable carrier containing an amount of said diamine which is effective in treating malaria.
Claim 23
Dependent Claim 35 words
The method of claim 18 wherein the effective dose for treating malaria is that dose which is toxic to the malaria parasite infecting the host, but below the threshold of significant toxicity to the host.
Claim 24
Dependent Claim 14 words
An antimalarial composition comprising the compounds of claims 1-17 in a pharmaceutically acceptable carrier.

References Cited (Backward Citations)

US2050971A Cited
US2791582A Cited
US3027378A Cited
US3668207A Cited
US3948920A Cited
US3971789A Cited
US3875165A Cited
US3953453A Cited
US5110935A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-04-23 1999-10-23 2000-04-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-04-23 2003-10-23 2004-04-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-04-23 2007-10-23 2008-04-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag